This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly. CASES: We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy. CONCLUSIONS: Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Saçar et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: